H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 7.9% of adults in Salt Lake City have diagnosed diabetes — 4.1 points below the U.S. 12% figure. Census population 200,133. Utah Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Salt Lake City clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Salt Lake City storefront.
Growth Factor Therapy for Tissue Repair in Salt Lake City, UT for clinics & physicians. Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 18.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 7.9% of adults in Salt Lake City have diagnosed diabetes — 4.1 points below the U.S. 12% figure. Together those PLACES numbers are why a city under 250k still needs separate PRP and CTP protocols. growth factor therapy inventory is national; utilization is JF-local.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)JF reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Salt Lake City is 7.9% or not. PLACES is planning data. The LCD is the claim.
We are not going to invent a Salt Lake City warehouse or a five-star local review. What you get is growth factor therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JF, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 7.9% of adults — 4.1 points below the U.S. 12% figure. Obesity is 29.5%; arthritis is 18.9%. That is place-level BRFSS modeling, not a clinic census and not a Salt Lake City trial.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Utah compliance risk.
Ask for the IFU, the lot-traceability packet, and the Noridian Healthcare Solutions article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Salt Lake City fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Salt Lake City, UT.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Salt Lake City is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Salt Lake City — 4.1 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Utah Part B wound biologics follow this contractor (siblings: AK, AZ, ID, MT, ND, OR, SD, WA, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Salt Lake City. Useful for joint-program math; still needs a diagnosis and privileging.
No Salt Lake City storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.